23.054
Bearbeitungen
Änderungen
Zur Navigation springen
Zur Suche springen
Zeile 66:
Zeile 66: + + +
→Unveröffentlichte (Auftrags-)Studien zu Regividerm
*Explorative Phase II Clinical Trial on the Efficacy and Tolerability of Regividerm in Atopic Dermatitis, randomised, double-blind and placebo-controlled monocentre study with n=20 patients in intraindividual left/right side comparison. 2001, Universität Münster, Klinik Hornheide (Dr. Hans-Joachim Schulze)
*Explorative Phase II Clinical Trial on the Efficacy and Tolerability of Regividerm in Atopic Dermatitis, randomised, double-blind and placebo-controlled monocentre study with n=20 patients in intraindividual left/right side comparison. 2001, Universität Münster, Klinik Hornheide (Dr. Hans-Joachim Schulze)
*Regividerm in Psoriasis, randomised, double-blind and placebo-controlled monocentre study with n=21 patients in intraindividual left/right side comparison. 2002, Universität Münster Klink Hornheide (Dr. Hans-Joachim Schulze)
*Regividerm in Psoriasis, randomised, double-blind and placebo-controlled monocentre study with n=21 patients in intraindividual left/right side comparison. 2002, Universität Münster Klink Hornheide (Dr. Hans-Joachim Schulze)
===Abgebrochene Studien===
*Abgebrochene Studie ''Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis'' April 2007. Study ID Number: IRB00001369, ClinicalTrials.gov Identifier: NCT00465699 [http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00465699]
===Nebenwirkungen===
===Nebenwirkungen===